Specificity of Three Vasopressin Receptor Antagonists

E-ISSN： 1875-628x|8|6|529-535

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.6, 2011-07, pp. : 529-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Vasopressin Receptor Antagonists

By Ali Farhan Guglin Maya Vaitkevicius Peter Ghali Jalal K.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 847-858

Adis International

Access to resources Recommend Favorite

Vasopressin receptor antagonists in heart failure

By Thibonnier M.

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 683-687

Elsevier

Access to resources Recommend Favorite

The use of vasopressin receptor antagonists in hyponatremia

By Elhassan Elwaleed A Schrier Robert W

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 373-380

Informa Healthcare

Access to resources Recommend Favorite

Vasopressin receptor antagonists in the management of acute heart failure

By Tang WH Wilson Bhavnani Sanjeev Francis Gary S

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Pyrazinobenzodiazepines as Potent Nonpeptide Vasopressin Receptor Antagonists

Letters in Drug Design & Discovery, Vol. 2, Iss. 3, 2005-05 ,pp. : 219-223

Bentham Science Publishers

Access to resources Recommend Favorite